Nociplastic Pain in Patients With Chronic Shoulder Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-18

Study Completion Date

2025-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to investigate predictors of nociplastic shoulder pain. Factors of psychological distress, functionality, fitness, quality of life, quality of sleep, functioning of the parasympathetic system, and lifestyle will be examined. Patients with nociplastic pain will be identified using the classification system proposed by the IASP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neuropathic Spinal Pain in Ankylosing Spondylitis

NCT04809168

Ankylosing Spondylitis

ACTIVE_NOT_RECRUITING

Neuropathic Spinal Pain Descriptors in Ankylosing Spondylitis

NCT05096767

Ankylosing Spondylitis

RECRUITING

Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes

NCT05277025

Fibromyalgia Rheumatoid Arthritis

RECRUITING

Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia

NCT01167413

Fibromyalgia Ankylosing Spondylitis

UNKNOWN

Determining How the Nervous System Processes Pain in Adults With Fibromyalgia

NCT00496886

Fibromyalgia Rheumatoid Arthritis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main part of the study will include patients with chronic shoulder pain who visit the Hand Surgery-Upper Limb and Microsurgery Department of the General Hospital KAT. The measurements will be performed in one session. Once participants have been informed of the purpose and procedure of the study and given written consent, they will complete their demographics and a series of questionnaires and questions about their pain history. They will then be examined by a doctor and finally subjected to dynamometry, a functional test and two quantitative sensory tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nociplastic Pain Criteria

All participants will be assessed with the specific nociplastic pain criteria

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients (men and women) with chronic shoulder pain (lasting more than 3 months, 3/10 Numeric Pain Rating Scale),
* aged 18-65 years
* mentally able to follow instructions or
* healthy volunteers
* aged 18-65
* who do not experience pain and have not received analgesic medication in the last trimester.

Exclusion Criteria

* referred shoulder pain from different primary sources of pain (eg shoulder pain in women with mastectomy or stroke),
* pain manifested by movements in the neck,
* shoulder arthroplasty or fractures or dislocation of the shoulder, -
* diagnosis of chronic pain syndrome such as fibromyalgia, chronic fatigue syndrome, chronic regional pain syndrome, cancer diagnosis, osteoporosis, rheumatic inflammatory diseases,
* use of medication for neurological/psychiatric disorders,
* the presence of gastrointestinal or renal disease
* taking medication that may affect the assessment results, such as calcium channel blockers that could alter HRV,
* pregnancy or childbirth before 1 year will be excluded from the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes